Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis
Top Cited Papers
Open Access
- 1 January 2002
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hepatology
- Vol. 35 (1), 140-148
- https://doi.org/10.1053/jhep.2002.30082
Abstract
The extensive use of invasive procedures and of long‐term norfloxacin prophylaxis in the management of cirrhotic patients may have influenced the epidemiology of bacterial infections in cirrhosis. We conducted a prospective evaluation of all bacterial infections diagnosed in patients with cirrhosis in a Liver Unit between April 1998 and April 2000. A total of 405 patients presented 572 bacterial infections in 507 admissions. Spontaneous bacterial peritonitis was the most frequent infection (138 cases). Gram‐positive cocci were responsible for 53% of total bacterial infections in the study, being the main bacteria isolated in nosocomial infections (59%). Patients requiring treatment in an intensive care unit and those submitted to invasive procedures presented a higher rate of infections caused by gram‐positive cocci (77% vs. 48%, P < .001 and 58% vs. 40%, P < .02, respectively). Fifty percent of culture‐positive spontaneous bacterial peritonitis in patients on long‐term norfloxacin administration (n = 93) and 16% in patients not receiving this therapy (n = 414) were caused by quinolone‐resistant gram‐negative bacilli, P = .01. The rate of culture‐positive spontaneous bacterial peritonitis caused by trimethoprim‐sulfamethoxazole–resistant gram‐negative bacilli was also very high in patients on long‐term norfloxacin administration (44% vs. 18%, P = .09). In conclusion, infections caused by gram‐positive cocci have markedly increased in cirrhosis. This phenomenon may be related to the current high degree of instrumentation of cirrhotic patients. Quinolone‐resistant spontaneous bacterial peritonitis constitutes an emergent problem in patients on long‐term norfloxacin prophylaxis, with trimethoprim‐sulfamethoxazole not being a valid alternative.Keywords
Funding Information
- Fondo de Investigación Sanitaria (FIS 00/0921)
- Instituto de Salud Carlos III (BEFI 00/9380)
- Hospital Clínic
This publication has 27 references indexed in Scilit:
- Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus documentJournal of Hepatology, 2000
- Risk Factors for The Development of Bacterial Infections in Hospitalized Patients With CirrhosisThe American Journal of Gastroenterology, 1999
- Spontaneous Bacterial PeritonitisSeminars in Liver Disease, 1997
- Trimethoprim-Sulfamethoxazole for the Prevention of Spontaneous Bacterial Peritonitis in CirrhosisAnnals of Internal Medicine, 1995
- Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitisAntimicrobial Agents and Chemotherapy, 1994
- A prospective study of bacterial infections in patients with cirrhosisJournal of Hepatology, 1993
- Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trialJournal of Hepatology, 1990
- Optimization of ascitic fluid culture techniqueGastroenterology, 1988
- Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infectionsJournal of Hepatology, 1985
- Culture-Negative Neutrocytic Ascites: A Variant of Spontaneous Bacterial PeritonitisJournal of Hepatology, 1984